"Established in 2002, at Compassionate Cancer Care & Research Center we practice world class medicine by board certified hematologists and oncologists trained at the top University hospitals in the country. In our private practice setting you will find friendly, personal staff that develop relationships with you throughout your treatment. We also conduct some of the world's leading clinical trials for cancer treatments available at all our centers. We provide the newest, innovative treatments to help maximize your outcome and prognosis. We offer a comprehensive range of services and have the resources available to help each patient in their fight against cancer."

During the past decade, Compassionate Cancer Care Medical Group, Inc conducted 49 clinical trials. In the 10-year time frame, 49 clinical trials started and 35 clinical trials were completed, i.e. on average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 23 clinical trials were completed. i.e. 127.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Compassionate Cancer Care Medical Group, Inc" #1 sponsor was "Bristol-Myers Squibb" with 11 trials, followed by "Novartis Pharmaceuticals" with 5 trials sponsored, "Pfizer" with 4 trials sponsored, "Clovis Oncology, Inc." with 3 trials sponsored and "Eli Lilly and Company" with 3 trials sponsored. Other sponsors include 52 different institutions and companies that sponsored additional 49 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Compassionate Cancer Care Medical Group, Inc" #1 collaborator was "AbbVie" with 3 trials as a collaborator, "Bayer" with 2 trials as a collaborator, "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "Parexel" with 2 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Compassionate Cancer Care Medical Group, Inc" are "Multiple Myeloma" (11 trials), "Breast Cancer" (6 trials), "Carcinoma, Non-Small-Cell Lung" (6 trials), "Non-Small Cell Lung Cancer" (5 trials) and "Metastatic Breast Cancer" (4 trials). Many other conditions were trialed in "Compassionate Cancer Care Medical Group, Inc" in a lesser frequency.

Most popular intervention types in "Compassionate Cancer Care Medical Group, Inc" are "Drug" (77 trials), "Biological" (9 trials), "Other" (4 trials), "Combination Product" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Dexamethasone" (9 trials), "Lenalidomide" (6 trials), "Docetaxel" (5 trials) and "Fulvestrant" (4 trials). Other intervention names were less common.

The vast majority of trials in "Compassionate Cancer Care Medical Group, Inc" are 75 trials for "All" genders, 5 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Compassionate Cancer Care Medical Group, Inc". undefined are not yet recruiting, 10 are recruiting, 9 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 39 completed trials in Compassionate Cancer Care Medical Group, Inc, undefined suspended trials, and 18 terminated clinical trials to date.

Out of the total trials that were conducted in Compassionate Cancer Care Medical Group, Inc, 7 "Phase 1" clinical trials were conducted, 33 "Phase 2" clinical trials and 39 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 0 trials that are defined as “Not Applicable".